- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Pfizer to develop clinical trial website
21 August 2009
Pfizer is entering into a collaboration with Private Access, a company specialising in privacy-enhanced search technology, to build a new online community where patients can find out about clinical trials of new drugs and where doctors, companies and researchers can search for test subjects.
"Many patients who could benefit from participation in clinical trials don't enrol in them because they are not aware that potentially relevant research is unde way or they cannot find a specific trial to meet their needs; other woprry that they will lose control of their health information," commented Freda Lewis-Hall, Pfizer's chief medical officer in a press release.
"With unprecedented collaboration among key groups, Pfizer and Private Access believe we can build the preeminent online clinical trial community to be used industry-wide to share knowledge while giving patients the confidence and control to share their health information."
The key to Private Access' technology is that allows patients to control to whom and what purpose they consent access to all, or selected areas, of their personal health information.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
